Psoriasiform Dermatitis in a COVID-19 Patient
Psoriasis is a chronic inflammatory papulosquamous disorder which affects around 2% of the world's population. A peak exacerbation in psoriatic symptoms was noted during COVID-19 due to lack of access to dermatological care mixed with heightened emotional stress during the pandemic. This case r...
Saved in:
Main Authors: | Marlyn Wu (Author), Shereen Teymour (Author), Robin Ashinoff (Author), Hira Ghani (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COVID-19 vaccine-associated dermatomyositis
by: Marlyn Wu, DO, et al.
Published: (2022) -
Histopathological spectrum of Psoriasiform dermatitis
by: PL Jayalakshmy, et al.
Published: (2016) -
Relapsed angioimmunoblastic T-cell lymphoma presenting as psoriasiform dermatitis
by: Spencer McClure, MD, et al.
Published: (2023) -
Dermal vasculature in psoriasis and psoriasiform dermatitis: A morphometric study
by: Shilpa Gupta, et al.
Published: (2011) -
Psoriasiform dermatitis in a person of colour with chronic hepatitis B
by: Paloma A. Seidel, et al.
Published: (2024)